Vestal Point Capital, LP 13D and 13G filings for Day One Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 5:02 pm Sale | 2026-03-31 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | Vestal Point Capital, LP | 0 0.000% | -5,200,000 (Position Closed) | Filing |
| 2026-02-17 4:06 pm Purchase | 2025-12-31 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | Vestal Point Capital, LP | 5,200,000 5.100% | 5,200,000 (New Position) | Filing |